Bioprocess Containers Market Report 2026

Bioprocess Containers Market Overview

• Bioprocess Containers market size has reached to $6.39 billion in 2025 • Expected to grow to $22.19 billion in 2030 at a compound annual growth rate (CAGR) of 28.3% • Growth Driver: Increasing Demand For Biologics And Biosimilars • Market Trend: Adoption Of High-Strength Single-Use Films To Improve Reliability In Bioprocess Containers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Bioprocess Containers Market?

Bioprocess containers are single-use containers that are used for critical sterile liquid-handling applications in the biopharmaceutical industry. It is used for liquid cell culture media, reagents, buffers, containment, and storage vessels for intermediate and final products yielded from manufacturing processes. The main types of bioprocess containers include 2D bioprocess containers, 3D bioprocess containers, tank liners, and other containers and accessories. The 2D bioprocess container refers to bioprocess containers with a two-dimensional design for sterile liquid handling. They are designed for small, simple BPCs from 50 ML to 50 L. It is produced from two sheets of film, heat-sealed around the perimeter to form a pillow-shaped chamber. These containers are used in biopharmaceutical companies, life science R&D companies, and others for upstream & downstream process, and product development applications.

What Is The Bioprocess Containers Market Growth Forecast?

The bioprocess containers market size is expected to see exponential growth in the next few years. It will grow to $22.19 billion in 2030 at a compound annual growth rate (CAGR) of 28.3%. The growth in the forecast period can be attributed to increasing investments in cell and gene therapy manufacturing, rising focus on modular bioprocess facilities, expansion of contract biomanufacturing, growing emphasis on sustainability in bioprocessing, increasing demand for scalable production platforms. Major trends in the forecast period include increasing adoption of single-use bioprocessing systems, rising demand for flexible and scalable biomanufacturing, growing use of sterile liquid handling solutions, expansion of cell and gene therapy production, enhanced focus on contamination risk reduction.

Global Bioprocess Containers Market Segmentation

1) By Type: 2D Bioprocess Containers, 3D Bioprocess Containers, Tank Liners, Other Containers & Accessories 2) By Application: Process Development, Upstream, Downstream 3) By End User: Biopharmaceutical Companies, Life Science R&D Companies, Other End Users Subsegments: 1) By 2D Bioprocess Containers: Single-Use Bags, Flexible Film Containers 2) By 3D Bioprocess Containers: Bioreactor Bags, 3D Cell Culture Containers 3) By Tank Liners: Protective Liners, Flexible Tank Liners 4) By Other Containers & Accessories: Connectors and Tubing, Manifolds, Holders and Racks

What Is The Driver Of The Bioprocess Containers Market?

The increasing demand for biologics and biosimilars is expected to propel the growth of the bioprocess containers going forward. Biologics and biosimilars are types of medications used to treat various illnesses. Bioprocess containers, particularly those designed for single-use applications, offer significant advantages in terms of flexibility, scalability, cost-efficiency, and reduced risk of contamination. These benefits make them well-suited for the dynamic and rapidly evolving field of biologics and biosimilars manufacturing. For instance, in June 2024, according to the Cardinal Health Inc., a US-based healthcare company, there are 40 Food and Drug Administration (FDA) approved biosimilar products in 2023, 25 of which are commercially available in the US market, an increase from 33 biosimilar products in 2022. Therefore, increasing demand and usage of biologics and biosimilars drives the bioprocess container industry.

Key Players In The Global Bioprocess Containers Market

Major companies operating in the bioprocess containers market are Sartorius Stedim Biotech S.A., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Sartorius AG, Compagnie de Saint-Gobain S.A., Lonza Group AG, Avantor Inc., Eppendorf AG, Meissner Filtration Products Inc., Corning Incorporated, GE Healthcare Technologies Inc., Fluids Control Inc., Neta Scientific Incorporated, ALLpaQ Packaging Group plc, Kawasumi Laboratories Inc., F.L. Medical SRL, Sani-Tech West Inc., Cellon SA, Celltainer Biotech BV, Entegris Inc., Flexboy AG, GE Healthcare Life Sciences, GEA Group AG, GEMÜ Group, GVS Group Ltd., Integra Companies, Kuhner AG

Global Bioprocess Containers Market Trends and Insights

Major companies are operating in the bioprocess containers market, focusing on developing advanced materials such as high-strength, leak-resistant multilayer films to enhance container durability, reduce contamination risk, and support large-volume biologics manufacturing. These next-generation films use reinforced polymer architectures designed to deliver superior tensile strength, puncture resistance, and low extractables compared to traditional single-use films. For instance, in April 2023, Merck KGaA, a Germany-based life sciences and technology company, launched the Ultimus Single-Use Process Container Film engineered for demanding bioprocessing applications. The film incorporates a proprietary woven-nylon strength layer, paired with a medical-grade polyethylene contact layer and gas-barrier components to ensure stability in upstream and downstream workflows. It offers up to ten times greater abrasion resistance and significantly improved leak prevention, enabling safer handling of high-value biologics while maintaining compatibility with Merck’s Mobius 3D bioprocess containers.

What Are Latest Mergers And Acquisitions In The Bioprocess Containers Market?

In May 2024, Novo Holdings, a Denmark-based investment company, acquired Single Use Support for an undisclosed amount. The aim of the acquisition is to strengthen Novo Holdings' life sciences services and manufacturing capabilities to more effectively support pharmaceutical companies in managing biologics and advanced therapies. Single Use Support is an Austria-based life sciences tools company that offers fluid management services tailored for the pharmaceutical industry, emphasizing fluid and cold-chain management of pharmaceutical substances.

Regional Outlook

North America was the largest region in the bioprocess containers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Bioprocess Containers Market?

The bioprocess containers market consists of sales of Standard BioProcess Containers, Bioprocessing Films, Fluid Transfer Solutions, and Retention Devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.